European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes
NCT ID: NCT01239589
Last Updated: 2011-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1280 participants
OBSERVATIONAL
2010-11-30
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder
NCT01455961
Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey
NCT00660712
Effect of Quetiapine on Brain Activity Patterns in Patients With Heightened Risk of Bipolar Disorder
NCT02451306
Depressive Symptoms in Acute Manic Episode
NCT00690248
Evaluation of Sub-syndromal Symptoms After Acute Depressive Episode in Bipolar Disorder
NCT01663974
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
patients admitted as for an acute bipolar manic episode and treated with quetiapine IR
No interventions assigned to this group
2
patients admitted as for an acute bipolar manic episode and treated with quetiapine XR
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted for acute bipolar manic episode from 1st October 2009 to 1st October 2010
* Patients treated with quetiapine IR or quetiapine XR during the hospitalization period.
Exclusion Criteria
* Patients admitted for acute bipolar mania episodes but finally diagnosed with mixed or bipolar disorder not otherwise specified (NOS) episodes
* Patients receiving both quetiapine IR and XR during the same hospitalization period.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Lamezia Terme, Catanzaro, Italy
Research Site
Cosenza, Cosenza, Italy
Research Site
Assebroek, Belgium, Belgium
Research Site
Bertrix, Belgium, Belgium
Research Site
Bruges, Belgium, Belgium
Research Site
Ghent, Belgium, Belgium
Research Site
Godinne, Belgium, Belgium
Research Site
Ixelles-Elsene, Belgium, Belgium
Research Site
Koksijde, Belgium, Belgium
Research Site
Malle, Belgium, Belgium
Research Site
Marchienne-au-Pont, Belgium, Belgium
Research Site
Montignies-sur-Sambre, Belgium, Belgium
Research Site
Ottignies, Belgium, Belgium
Research Site
Overpelt, Belgium, Belgium
Research Site
Roeselaere, Belgium, Belgium
Research Site
Zagreb, City of Zagreb, Croatia
Research Site
Split, Split, Croatia
Research Site
Augustenborg, Augustenborg, Denmark
Research Site
Bispebjerg, Bispebjerg, Denmark
Research Site
Br�nderslev, Br�nderslev, Denmark
Research Site
Odense, Odense, Denmark
Research Site
Helsingin Kaupunki, Helsingin Kaupunki, Finland
Research Site
Jyv�skyl�, Jyv�skyl�, Finland
Research Site
Kellokoski, Kellokoski, Finland
Research Site
Ekenäs, Tammisaari, Finland
Research Site
Ulm, Baden-W�rttemberg, Germany
Research Site
Cham, Bavaria, Germany
Research Site
Neu�tting, Bavaria, Germany
Research Site
Regensburg, Bavaria, Germany
Research Site
Wasserburg am Inn, Bavaria, Germany
Research Site
W�rzburg, Bavaria, Germany
Research Site
Bielefeld, Lower Saxony, Germany
Research Site
Hildesheim, Lower Saxony, Germany
Research Site
Liebenburg, Lower Saxony, Germany
Research Site
Greifswald, Mecklenburg-Vorpommern, Germany
Research Site
Bochum, North Rhine-Westphalia, Germany
Research Site
Berlin, State of Berlin, Germany
Research Site
Ascoli Piceno, Ascoli Piceno, Italy
Research Site
Bologna, Bologna, Italy
Research Site
Ceglie Messapica, Brindisi, Italy
Research Site
San Pietro Vernotico, Brindisi, Italy
Research Site
Cuneo, Cuneo, Italy
Research Site
Ferrara, Ferrara, Italy
Research Site
Foggia, Foggia, Italy
Research Site
Loc. S. Marciano (Sora), Frosinone, Italy
Research Site
S. Agata Militello, Messina, Italy
Research Site
Mestre, Mestre, Italy
Research Site
Pisa, Pisa, Italy
Research Site
Roma, Roma, Italy
Research Site
Sassari, Sassari, Italy
Research Site
Teramo, Teramo, Italy
Research Site
Conegliano, Treviso, Italy
Research Site
Adana, Adana, Turkey (Türkiye)
Research Site
Ankara, Ankara, Turkey (Türkiye)
Research Site
Ayd?n, Ayd?n, Turkey (Türkiye)
Research Site
Bolu, Bolu, Turkey (Türkiye)
Research Site
Diyarbakır, Diyarbakır, Turkey (Türkiye)
Research Site
Elâzığ, Elâzığ, Turkey (Türkiye)
Research Site
Erzurum, Erzurum, Turkey (Türkiye)
Research Site
Istanbul, Istanbul, Turkey (Türkiye)
Research Site
Kayseri, Kayseri, Turkey (Türkiye)
Research Site
Konya, Konya, Turkey (Türkiye)
Research Site
Manisa, Manisa, Turkey (Türkiye)
Research Site
Samsun, Samsun, Turkey (Türkiye)
Research Site
Sivas, Sivas, Turkey (Türkiye)
Research Site
Trabzon, Trabzon, Turkey (Türkiye)
Research Site
Zonguldak, Zonguldak Province, Turkey (Türkiye)
Research Site
Sanliurfa, Şanlıurfa, Turkey (Türkiye)
Research Site
Bury St Edmunds, Bury Saint Edmunds, United Kingdom
Research Site
Winsford, Cheshire, United Kingdom
Research Site
Coventry, Coventry, United Kingdom
Research Site
Hull, Hull, United Kingdom
Research Site
Dartford, Kent, United Kingdom
Research Site
Leeds, Leeds, United Kingdom
Research Site
Leicester, Leicester, United Kingdom
Research Site
Ealing, London, United Kingdom
Research Site
London, London, United Kingdom
Research Site
Prescot, Merseyside, United Kingdom
Research Site
Newcastle upon Tyne, Newcastle (Upon Tyne), United Kingdom
Research Site
Norwich, Norfolk, United Kingdom
Research Site
Taunton, Somerset, United Kingdom
Research Site
Cannock, Staffordshire, United Kingdom
Research Site
Chertsey, Surrey, United Kingdom
Research Site
Wolverhampton, West Midlands, United Kingdom
Research Site
Pulborough, West Sussex, United Kingdom
Research Site
Bradford, Yorkshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Karamustafalioglu O, Reif A, Atmaca M, Gonzalez D, Moreno-Manzanaro M, Gonzalez MA, Medina E, Bellomo A. Hospital stay in patients admitted for acute bipolar manic episodes prescribed quetiapine immediate or extended release: a retrospective non-interventional cohort study (HOME). BMC Psychiatry. 2014 Aug 31;14:246. doi: 10.1186/s12888-014-0246-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NEU-SER-2010/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.